Targeting vaccine campaigns only at vulnerable groups in future will, paradoxically, leave them at greater risk.
- Professor of Cancer Virology, University of Leeds
In particular, a drug called Evusheld could offer protection for people who are vulnerable – but the UK isn’t offering it.
For one, washing your hands is unlikely to prevent COVID spread.
We hear a lot about drug-resistant bacteria. The same thing can happen with viruses.
Severe COVID disease is rare in children, but high case numbers are seeing more kids being affected.
Under a quarter of 12- to 15-year-olds are double vaccinated, while vaccines for younger children are still yet to be rolled out.
A promising new immunotherapy to treat liver cancer has been discovered.
Contact Stephen for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Leeds, UK
- Website
- X (formerly Twitter): @SGriffin_Lab
- Article Feed
- ORCID
- Joined
